Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Digene Infrastructure Scale-Up For DNA Pap Could Follow Failed Cytyc Merger

This article was originally published in The Gray Sheet

Executive Summary

Digene may decide to expand its sales infrastructure for marketing the HPV DNA Pap test as a primary screen for cervical cancer if its pending merger with Cytyc does not occur

You may also be interested in...



Digene Physician Detailing Pact With PDI Tops DNAwithPap Launch Strategy

Digene does not plan to extend a co-promotion pact with Cytyc for its DNAwithPap test after signing on PDI to set up a U.S. physician detailing organization

Digene Physician Detailing Pact With PDI Tops DNAwithPap Launch Strategy

Digene does not plan to extend a co-promotion pact with Cytyc for its DNAwithPap test after signing on PDI to set up a U.S. physician detailing organization

ThinPrep Pricing Level Improvement Drives Cytyc Q1 Revenues To $72.6 Mil.

Cytyc anticipates a second quarter launch for the ThinPrep automated imaging and review system, which is used with the company's cervical cancer screening test

Related Content

UsernamePublicRestriction

Register

MT016791

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel